baber/WOPTO huggingface dataset:
Patent DE-06750058-T1 (DE)
Title: Hydraulisches system für ein nutzfahrzeug
Inventor: PASSERI GIANNI
IPC: B66F9/10
Filed: 2006-04-14
Abstract: Ein
industrielles Fahrzeug aufweisend:  eine Hebevorrichtung;  ein
Haupthydrauliksystem, das zwei oder mehrere Pumpenmotoren hat, welche
die Hebevorrichtung mit Hydraulikflüssigkeit versorgen;  eine
Lasthandhabungseinrichtung; und  ein zweites Hydrauliksystem,
das mit dem Haupthydrauliksystem hydraulisch verbunden ist, wobei
das Haupthydrauliksystem den Hydraulikfluss von einem der zwei oder
mehr Pumpenmotoren zu dem zweiten Hydrauliksystem abzweigt, wenn
eine Betätigung
der Lasthandhabungseinrichtung erkannt wird.
Patent DE-152799-T1 (DE)
IPC: A61K31/495
Filed: 1985-01-25
Abstract: 1-(4,4 min -Difluorobenzhydryl)-4(-3,4-dimethoxycinnamyl)piperazine, processes for the preparation thereof by reacting a reactive derivative of 3,4-dimethoxycinnamic acid with 1-(4,4 min -difluorobenzhydryl)-piperazine and subsequently reducing the carbo-amido bond formed, or by directly condensing cinnamyl halide on 1-benzhydrylpiperazine.
Patent DE-240093-T1 (DE)
IPC: E06B3/677
Filed: 1985-05-03
Abstract: Appts. has a drill spindle that is positioned in a chamber and has a sealing element between its outer wall and the internal wall of the chamber. The spindle is driven by fluid which is supplied to the appts under an overpressure and is used for lubrication and/or cooling.
Patent DE-365269-T1 (DE)
IPC: A61F2/95
Filed: 1989-10-17
Abstract: An indwelling ureteral stent positioning apparatus (10) is provided for allowing single intrusion placement of a stent (20) in the ureter of a patient. The apparatus is pre-assembled and includes a wire guide (12) with floppy tip (14). The stent (20) is positioned about the wire guide (12) adjacent to the floppy tip (14) of the wire guide (12), and is adjustably situated on the wire guide (12) to expose a pre-determined length of the floppy tip (14) for insertion into the patient. The stent (20) is a dual open-ended tubular stent having a resilient retentive curved circular or pigtail shape at each end for retention in the kidney and bladder. A positioner (25) is conveyed on the wire stent until the end of the positioner abuts the anatomically distal end (24) of the stent (20). A pin-vise clamp (30) abuts the external end of the positioner (25) and releasably engages the wire guide (12) to stabilize the apparatus (10) during insertion. When used to position the stent (20) within the ureter, the apparatus (10) is conveyed along the ureter until the floppy tip (14) is within the renal collecting system. The positioner (25) is advanced along the wire guide (12) to push the anatomically proximal end (23) of the stent (20) over and beyond the floppy tip (14) so that the retentive coil forms within the kidney. The pin-vise clamp (30) is released to allow the wire guide (12) to be withdrawn until it passes the anatomically distal end (24) of the stent (20), wherein the retentive coil shape is formed within the bladder. With the stent fully indwelling, the positioner (25) and wire guide (12) are removed from the patient. <IMAGE>
Patent ES-2171363-T1 (ES)
Inventor: SEGBERT STEPHAN
IPC: B65G57/10
Filed: 2000-08-16
Abstract: Two feeder conveyors (3,4) convey stacks (1) which have a transporter carriage (6) positioned between the two feeder conveyors in a loading position. At least one layer from a number of adjacent stacked rows (5) is transferred onto the transporter-carriage which is moved to an unloading position in which the carriage is positioned between two discharge conveyors (18,19). The layer from the transporter-carriage is transferred onto a pallet (2) on a discharge conveyor.
Patent ES-2042447-T1 (ES)
Title: Dispositivo de acoplamiento rapido para la union estanca entre si de dos tubos o tuberias rigidos o semirrigidos.
Inventor: GODEAU DENIS
IPC: F16L37/098
Filed: 1992-12-07
Abstract: DISPOSITIVO DE ACOPLAMIENTO RAPIDO PARA LA CONEXION ESTANCA ENTRE SI DE DOS TUBOS O TUBERIAS RIGIDOS O SEMIRRIGIDOS QUE COMPRENDE UNA JUNTA HERMETICA CONSTITUIDA POR UN MANGUITO (41) QUE PRESENTA EN UNO DE SUS EXTREMOS LAMINAS ELASTICAS (20, 20'') FIJADAS SOBRE UN TUBO O TUBERIA (10) QUE DISPONEN DE MEDIOS DE BLOQUEO (241,242) DESTINADOS A COOPERAR CON LA SUPERFICIE EXTERNA (45) O UN COLLARIN DEL OTRO TUBO O TUBERIA (35,35'').
Patent CY-1109382-T1 (CY)
Inventor: ALLAN BARRETT W
IPC: C07K16/00
Filed: 2009-09-18
Abstract: The present invention provides polypeptide Fc region variants and oligonucleotides encoding Fc region variants. Specifically, the present invention provides compositions comprising novel Fc region variants, methods for identifying useful Fc region variants, and methods for employing Fc region variants for treating disease.
Patent CY-1111669-T1 (CY)
Inventor: CHERN REY T
IPC: B32B5/16
Filed: 2011-05-16
Abstract: Controlled release of hydrophobic bioactive substances in vivo over an extended time period and without "bursts" of drug release achieved using a liquid polymeric composition including a polymer such as poly(lactide-co-glycolide) copolymer in a mixture of hydrophilic and lipophilic solvents.
Patent CY-1111836-T1 (CY)
Inventor: NIROGI RAMAKRISHNA
IPC: C07D401/12
Filed: 2011-09-14
Abstract: The present invention relates to novel aminoalkoxy arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT6 receptor functions. Specifically, the compounds of this invention are also useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardiovascular diseases and cancer.
Patent CY-1115579-T1 (CY)
Title: Πλακα επικαλυψης δαπεδου και επικαλυψη δαπεδου αποτελουμενη απο μια πληθωρα τετοιων πλακων επικαλυψης δαπεδου
Inventor: PERRA ANTONIO GIUSEPPE
IPC: E04F15/02
Filed: 2014-06-19
Abstract: Η εφεύρεση αναφέρεται σε μια πλάκα επικάλυψης δαπέδου, ειδικότερα σε μία πολυστρωματική πλάκα επικάλυψης δαπέδου. Η εφεύρεση αναφέρεται επίσης σε μία επικάλυψη δαπέδου αποτελούμενη από μία πληθώρα αμοιβαία συζευγμένων πλακών δαπέδου σύμφωνα με την εφεύρεση. Η εφεύρεση αναφέρεται επιπλέον σε μία μέθοδο για την αμοιβαία σύζευξη δύο πλακών δαπέδου, ειδικότερα πολυστρωματικών πλακών δαπέδου σύμφωνα με την εφεύρεση.
Patent CY-1115348-T1 (CY)
Title: Διαταξη παρεμβυσματος ακτινικης στεγανωσης
Inventor: GRIMANIS MICHAEL P
IPC: F16J15/40
Filed: 2014-07-21
Abstract: Μια διάταξη παρεμβύσματος ακτινικής στεγάνωσης για την παροχή στεγανωτικού παρεμβύσματος μεταξύ άξονα και στατικής επιφάνειας περιλαμβάνει δακτύλιο στεγανοποίησης που διαμορφώνει περίβλημα για στήριξη της διάταξης παρεμβύσματος στο σταθερό εξοπλισμό, χιτώνιο που στηρίζεται σε άξονα και κινείται με αυτόν, ο οποίος άξονας εκτείνεται από το σταθερό εξοπλισμό, και εξάρτημα στεγάνωσης που φιλοξενείται μεταξύ του δακτυλίου στεγανοποίησης και του χιτωνίου για να σφραγίζει τον ενδιάμεσο χώρο. Το εξάρτημα στεγάνωσης περιλαμβάνει τουλάχιστον μία επιφάνεια παρεμβύσματος που εκτείνεται αξονικά προς τα εμπρός και τουλάχιστον μία επιφάνεια παρεμβύσματος που εκτείνεται αξονικά προς τα πίσω για να παρέχει στεγάνωση υπό συνθήκες κανονικής και αντίστροφης πίεσης. Το χιτώνιο είναι δυνατόν να περιλαμβάνει αξονικά εσωτερική κωνική απόληξη με διπλή γωνία εισόδου για να διευκολύνει τη συναρμολόγηση, ελαχιστοποιώντας παράλληλα το μήκος της διάταξης παρεμβύσματος.
Patent CY-1118790-T1 (CY)
Title: Μεθοδοι και συστηματα για ασφαλη επαληθευση ταυτοτητας χρηστη
Inventor: GRANDCOLAS MICHAEL
IPC: H04L29/06
Filed: 2016-12-28
Abstract: Μέθοδος και σύστημα που εκτελούνται από υπολογιστή για ασφαλή επαλήθευση ταυτότητας χρήστη στο ηλεκτρονικό εμπόριο αφορούν στη διατήρηση ηλεκτρονικών πληροφοριών που έχουν πρώτη άποψη προσβάσιμη μέσω πρώτου καναλιού ηλεκτρονικής επικοινωνίας όταν ο χρήστης εισάγει πρώτο διαπιστευτήριο γνωστό σε αυτόν και δεύτερη άποψη προσβάσιμη από το χρήστη μέσω του πρώτου καναλιού ηλεκτρονικής επικοινωνίας όταν αυτός εισάγει δεύτερο διαπιστευτήριο που παρέχεται σε αυτόν σε προκαταχωρημένη διεύθυνση παράδοσης μέσω δεύτερου καναλιού ηλεκτρονικής επικοινωνίας. Το δεύτερο διαπιστευτήριο παρέχεται στο χρήστη μέσω του δεύτερου καναλιού ηλεκτρονικής επικοινωνίας όταν αυτός εισάγει προκαθορισμένη επιλογή χρήστη σε μια τρέχουσα συνεδρία πρόσβασης χρήστη στην πρώτη άποψη, με την προϋπόθεση ότι δεν έχει γίνει αλλαγή στην προκαταχωρημένη διεύθυνση παράδοσης εντός προκαθορισμένης χρονικής περιόδου, και ο χρήστης εξουσιοδοτείται να διεξάγει συνεδρία πρόσβασης στη δεύτερη άποψη όταν εισάγει το δεύτερο διαπιστευτήριο είτε κατά την τρέχουσα συνεδρία πρόσβασης χρήστη στην πρώτη άποψη είτε στην επόμενη συνεδρία πρόσβασης χρήστη στην πρώτη άποψη.
Patent CY-1120958-T1 (CY)
Title: Ενημερωτικη πινακιδα με αντικολλητικο υμενιο καθως και μεθοδος για την παραγωγη αυτης
Inventor: ILGAY VEDAT
IPC: C09D5/28
Filed: 2018-09-25
Abstract: Η παρούσα εφεύρεση αφορά ενημερωτική πινακίδα η οποία περιλαμβάνει επίπεδη ταμπέλα με τουλάχιστον μία πλευρά ενδείξεως, όπου πάνω στην πλευρά ενδείξεως έχει εφαρμοστεί αντικολλητική επίστρωση, η οποία πινακίδα χαρακτηρίζεται από το ότι η αντικολλητική επίστρωση είναι ανεπτυγμένη ως διαφανές υμένιο και διαθέτει επιφάνεια με σημειακά υψώματα κατανεμημένα ακανόνιστα.
Patent CY-1122907-T1 (CY)
Title: Διαγνωστικες αναλυσεις και kit για ανιχνευση υποδοχεα φολικου 1
Inventor: TESTA NATHAN E
IPC: C07K16/30
Filed: 2020-04-30
Abstract: Η εφεύρεση γενικά αφορά αντισώματα τα οποία δεσμεύονται με ανθρώπινο υποδοχέα φολικού 1 και διαγνωστικές αναλύσεις για θεραπείες με βάση ανθρώπινο υποδοχέα φολικού 1. Παρέχονται περαιτέρω μέθοδοι χρήσης των αντισωμάτων για την παρακολούθηση της θεραπείας.
Patent HR-P20120187-T1 (HR)
Inventor: BARONI MARCO
IPC: A61P29/00
Filed: 2012-02-27
Abstract: Spoj formule (I): naznačen time što:-	m je 0 ili 1;-	A je: a B je atom vodikailiA je atom vodika, a B je: ;-	R1 i R2, koji mogu biti isti ili različiti, su neovisno atom vodika ili halogena, C1-C4 alkilna, C1-C4 fluoralkilna, C1-C2 perfluoralkilna ili C1-C4 alkoksi skupina ili trifluormetoksi skupina;-	n je 1 ili 2;-	R3 je skupina formule: gdje se R4 i R5, koji mogu biti isti ili različiti, nalaze na bilo kojem od dostupnih položaja i neovisno su atom vodika ili halogena, hidroksilna, C1-C4 alkilna, C1-C4 fluoralkilna, C1-C2 perfluoralkilna, C1-C4 alkoksi skupina, trifluormetoksi skupina, cijano skupina, COOH, COOalkilna, CONH2, CONR6R7 ili NHCOR skupina,-	R, R6 i R7 su C1-C6 alkil; u obliku baza ili adicijskih soli s kiselinama. Patent sadrži još 14 patentnih zahtjeva.
Patent HR-P20120511-T1 (HR)
Title: Spirocyclic cyclohexane derivatives
Inventor: STEFAN SCHUNK
IPC: A61P25/00
Filed: 2012-06-19
Abstract: Spirocyclic cyclohexane compounds corresponding to formula I in which R1 and R2 form a pyrrolidine ring or an azetidine ring and which exhibit increased metabolic stability, a process for producing such spirocyclic cyclohexane compounds, pharmaceutical compositions containing such spirocyclic cyclohexane compounds, and the use of such spirocyclic cyclohexane compounds to treat or inhibit pain and/or other disorders.
Patent SI-1902104-T1 (SI)
Title: Thermosetting powder paints
Inventor: BARDELLI ACHILLE ANGELO
IPC: C09D5/00
Filed: 2005-09-19
Abstract: Thermosetting colored powder paints to be used in electrostatic painting processes are described. These powder paints comprise not more than 30% by weight of at least one monochromatic pigment coated with at least one aldehyde and/or ketone resin, preferably 5 to 30% by weight, and up to 95% by weight of conversion agent, preferably 70 to 95% by weight; more than 90% of the particles of said at least one coated monochromatic pigment and said conversion agent have a particle size of between 10 and 40 microns, preferably between 15 and 35 microns. The coated monochromatic pigment and the conversion agent have the same specific weight which is between 1.3 and 1.7 g/cc.
Patent SI-2794666-T1 (SI)
Title: Use of chemically modified heparin derivates in sickle cell disease
Inventor: EKRE HANS-PETER
IPC: C08B37/00
Filed: 2012-12-19
Abstract: The present invention relates to chemically modified sulfated glycosaminoglycan derivatives selected from the group of heparin, heparan sulfate, dermatan sulfate and chondroitin sulphate with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. Also disclosed is a method of preparing the derivatives and their medical uses, including treatment of malaria and treatment of vaso-occlusive crisis in sickle cell disease.
Patent SI-2909188-T1 (SI)
Title: Novel process for making compounds for use in the treatment of cancer
Inventor: NAGANATHAN SRIRAM
IPC: C07D498/00
Filed: 2013-10-14
Abstract: Disclosed herein is a process of making a compound of formula I The compound of formula I is an inhibitor of MEK and thus can be used to treat cancer.
Patent DE-3587122-T2 (DE)
Inventor: MAKOVEC FRANCESCO
IPC: A61K31/405
Filed: 1985-12-05
Granted: 1993-07-15
Abstract: N-acylated derivatives of L-tryptophan of general formula (I), <IMAGE> (I)  in which R is selected from the group consisting of: (a) a phenyl group, mono-substituted or di-substituted in the meta and para positions with halogens, linear or branched alkyl groups containing from 1 to 9 carbon atoms, the cyano group or the trifluoromethyl group, (b) a benzyloxy group, mono-substituted or di-substituted in the meta and para position with substituents selected from those indicated at (a), and (c) a benzydryloxy group. The derivatives are used in therapy, particularly for human pain relief, in the treatment of pathological conditions of the central nervous system and of pathological intestinal conditions.
Patent DE-3588006-T2 (DE)
Inventor: JOHNSON LORIN
IPC: C12N15/12
Filed: 1985-04-16
Granted: 1995-08-10
Abstract: Methods and compositions for inducing natriuresis, diuresis and vasodilatation in mammalian hosts by administering atrial natriuretic/vasodilator polypeptides to said host. Also provided are methods for producing such polypeptides, and antibodies which are capable of recognizing and specifically binding to them.
Patent DE-3650488-T2 (DE)
Inventor: TYERS MICHAEL BRIAN
IPC: A61P1/00
Filed: 1986-06-24
Granted: 1996-09-05
Abstract: The invention relates to the use of compounds of the general formula (I)whereinR' represents a hydrogen atom or a C<sub>1-10</sub> alkyl, C<sub>3-7</sub> cycloalkyl, C<sub>3-7</sub> cycloalkyl-(C<sub>1-4</sub>) alkyl, C<sub>3</sub>-<sub>6</sub> alkenyl, C<sub>3-10</sub> alkynyl, phenyl or phenyl-C<sub>1-3</sub> alkyl group; and one of the groups represented byR<sup>2</sup>, R<sup>3</sup> and R<sup>4</sup> is a hydrogen atom or a C<sub>1-3</sub> alkyl, C<sub>3-7</sub>cycloalkyl, C<sub>2-6</sub> alkenyl or phenyl - C<sub>1-3</sub> alkyl group and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C<sub>1-6</sub> alkyl group; and physiologically acceptable salts and solvates thereof, for the relief of nausea and vomiting and/or the promotion of gastric emptying and for the manufacture of a medicament for this purpose. Promotion of gastric emptying may be for the relief of gastro-intestinal disorders associated with gastric stasis or may be of advantage in radiological examination procedures.The invention also relates to a product containing a therapeutic agent liable to induce nausea and vomiting, e.g. a cytostatic agent such as a cyclophosphamide, an alkylating agent or a platinum complex, and a compound of the general formula (1) as a combined preparation for simultaneous separate or sequential use in therapy.
Patent DE-3750615-T2 (DE)
Inventor: GOODCHILD JOHN
IPC: C12Q1/70
Filed: 1987-05-22
Granted: 1995-05-04
Abstract: Inhibition of HTLV-III by adminstration of an oligonucleotide complementary to highly conserved regions of the HTLV-III genome necessary for HTLV-III replication and/or gene expression is described, as are oligodeoxynucleotide sequences which are complementary to those regions, methods of inhibiting HTLV-III replication and gene expression and methods of determining the presence or absence of HTLV-III virus in samples such as blood, saliva, urine and tears.
Patent DE-3782642-T2 (DE)
Inventor: SOLA ANTONIO
IPC: B01F23/10
Filed: 1987-08-19
Granted: 1993-03-25
Abstract: PCT No. PCT/AU87/00277 Sec. 371 Date Jun. 20, 1988 Sec. 102(e) Date Jun. 20, 1988 PCT Filed Aug. 19, 1987 PCT Pub. No. WO88/01195 PCT Pub. Date Feb. 25, 1988.An apparatus to introduce a vaporized chemical agent into a compressed air supply system comprising an air inlet (25), a chemical agent storage chamber (15), and an air/chemical agent mixing chamber (13) which includes a baffle means (14) to promote turbulence and extract liquid phase chemical droplets. There is a supply means (17) to spray a controlled quantity of the chemical agent into the mixing chamber and an outlet (20) to allow removal of extracted liquid phase chemical agent from the mixing chamber (13).
Patent DE-3789378-T2 (DE)
Inventor: YOUNG DONALD C
IPC: A01N59/02
Filed: 1987-01-08
Granted: 1994-06-30
Abstract: Pests are controlled by applying to the location of and/or to the path traversed by the pests a composition comprising urea and sulfuric acid in which the urea/H2SO4 molar ratio is less than 2. Novel compositions useful in such methods are also provided and comprise the described combinations of urea and sulfuric acid dispersed in a hydrocarbon oil. the novel methods and compositions are particularly useful for controling plant pests by applying the useful urea-sulfuric acid components to the plants or to the vicinity of plants occupied or traversed by such pests.
Patent DE-3872017-T2 (DE)
Inventor: CAROBBI RENATO
IPC: C13K13/00
Filed: 1988-03-22
Granted: 1992-12-03
Abstract: Stable boron resins of high selective absorbent power and their production process. Said boron resins consist of a polyacrylic matrix functionalised with quaternary ammonium groups, an epoxy group and phenylboric groups in accordance with general formula (I): <CHEM>  in which P , R, R1, R2, R3, Y and X<-> are as defined in the text. The resin is prepared by condensing an acrylic resin with an epihalohydrin and then with a halide or hydroxide of an oxiphenyl-aminophenyl- or thiophenyl-boroxin or their alkyl derivatives. Compared with similar currently known resins, the resins of formula (I) have improved selectivity in sugar separation. They can be used for purifying lactulose.
Patent DE-3874369-T2 (DE)
Inventor: POZZOBON ALESSANDRO
IPC: A43B5/04
Filed: 1988-02-29
Granted: 1993-01-14
Abstract: The device comprises at least one interference element (5,105,205,305) slideably associated laterally to said at least one front quarter (3,103,203,303). Said interference element selectively interacts with one or more separate contrast elements (14,15,16,115,204,314,315) rigidly associated, with, and protruding from, said shell (2,202). The device furthermore comprises means (12) provided for locking said at least one interference element in a desired position.
Patent DE-3882606-T2 (DE)
Inventor: LIU MING-BIANN
IPC: C07C17/12
Filed: 1988-06-18
Granted: 1993-12-23
Abstract: Monobrominated cyclobutarenes are prepared by brominating a cyclobutarene in the presence of an organic complexing agent, an acid scavenger, or water. Faster reaction rates highly selective to monobrominated cyclobutarenes are obtained without conventional heavy metal or halogen catalysts.
Patent DE-3883320-T2 (DE)
Inventor: KLAPWIJK PIETER MARIE
IPC: C12N1/04
Filed: 1988-06-08
Granted: 1994-01-05
Abstract: A supported bacterial composition having a water activity of at most 0.2 comprises an inert subdivided support, eg. flour, and aqueous suspension of viable microflora. The composition has improved ambient stability and is usable in fermentation. The composition may contain an accelerant, eg. sucrose.
Patent DE-60002089-T2 (DE)
Inventor: COUARRAZE GUY
IPC: A61K9/50
Filed: 2000-07-25
Granted: 2004-02-05
Abstract: The invention concerns a microgranule tablet comprising a low dose of active principle containing a directly compressible diluent. The invention is characterised in that the directly compressible diluent consists exclusively of neutral microgranules, and the active principle is set on the neutral microgranules and is not coated with an agent designed to modify its release or mask its taste.
Patent DE-60002152-T2 (DE)
Inventor: KRILL DR
IPC: C07B61/00
Filed: 2000-09-28
Granted: 2004-01-08
Abstract: Production of alpha -tocopherol acetate in a recirculating process involves condensation of trimethylhydroquinone and isophytol in presence of a catalyst system comprising zinc halide and an aqueous protonic acid and optionally an elemental metal in a polar solvent/water mixture and subsequent acylation of the resultant alpha -tocopherol. Production of alpha -tocopherol acetate (I) in a recirculating process involves condensation of trimethylhydroquinone and isophytol in presence of a catalyst (II) system comprising zinc halide (IIa) and an aqueous protonic acid (IIb) and optionally an elemental metal in a polar solvent/water mixture extractable or miscible with water. The alpha -tocopherol initially obtained is separated from the aqueous catalyst phase and esterified with an acylating agent. The solution of (II) obtained after working up by aqueous extraction is regenerated and the solution containing acetic acid is returned to the reaction. (II) is concentrated and reintroduced into the reaction in liquid form.
Patent DE-60003493-T2 (DE)
Inventor: BAIKER ALFONS
IPC: B01J31/28
Filed: 2000-06-15
Granted: 2004-05-19
Abstract: The invention relates to a continuous process for enantioselective catalytic hydrogenation of an alpha ketocarbonyl compound such as alpha ketoesters and alpha ketolactones to produce an alpha hydroxy carbonyl compound.
Patent DE-60005905-T2 (DE)
Inventor: FRENKEL PETER
IPC: C07C409/22
Filed: 2000-05-25
Granted: 2004-08-19
Abstract: The process of preparing peroxyketals which comprises reacting a composition comprising ketone with hydroperoxide in the presence of heteropolyacid.
Patent DE-60011780-T2 (DE)
Inventor: MALSSEN KEES FREDERIK VAN
IPC: A23G1/00
Filed: 2000-07-24
Granted: 2005-07-14
Abstract: The invention relates to a method for the manufacture of chocolate, wherein liquid chocolate mass is mixed with seed material, and the mixture is cooled to below the melting temperature. According to the invention the seed material mixture is used having a temperature of at least 30  DEG C, and which has not exceeded the critical temperature. A chocolate manufactured in this manner will exhibit less or no fat bloom during prolonged storage.
Patent DE-60016029-T2 (DE)
Inventor: MAN HON-WAH
IPC: A61P1/02
Filed: 2000-12-19
Granted: 2005-10-20
Abstract: Substituted 1,3,4-oxadiazole compounds reduce the levels of TNF± in a mammal. Typical embodiment are 2-[1-(3-cyclopentyloxy-4-methoxyphenyl)-2-(1,3,4-oxadiazol-2-yl)ethyl]-5-methylisoindoline-1,3-dione and 2-[1-(3-ethoxy-4-methoxyphenyl)-2-(1,3,4-oxadiazol-2-yl)ethyl]isoindoline-1,3-dione.